Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome

BACKGROUND: Bifidobacterium longum 35624 has shown efficacy in improving irritable bowel syndrome (IBS) symptoms compared with placebo in double-blind randomized studies. However, few data are available from real-life clinical practice or from studies that used Rome IV criteria to diagnose IBS. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabaté, Jean-Marc, Iglicki, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891724/
https://www.ncbi.nlm.nih.gov/pubmed/35317278
http://dx.doi.org/10.3748/wjg.v28.i7.732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891724/
https://www.ncbi.nlm.nih.gov/pubmed/35317278
http://dx.doi.org/10.3748/wjg.v28.i7.732

Ejemplares similares